Publication | Open Access
198TiP SPOTLIGHT: Phase III study of zolbetuximab + mFOLFOX6 versus placebo + mFOLFOX6 in first-line Claudin18.2⁺/HER2⁻ advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
11
Citations
0
References
2020
Year
Molecular PharmacologyGastrointestinal OncologyGastrointestinal PharmacologyMedicinePharmacologyGastroenterologyPathologyClinical PharmacologyPharmacotherapyMetastatic GastricCancer TreatmentOncologyPhase Iii StudyCancer ResearchFirst-line Claudin18.2⁺/her2⁻
No additional data available for this publication yet. Check back later!